Clinical Trial Update: Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia

View source ↗

Summary

A clinical trial is currently recruiting to compare the efficacy and safety of Carcemia, a generic imatinib, with Glivec in the real-world management of chronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Carcemia (imatinib)
• Glivec (imatinib)

Snippet

Sponsor: Hikma Pharmaceuticals LLC | Conditions: Chronic Myeloid Leukemia | Status: RECRUITING